Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Boston Scientific Neuromodulation Corporation
FDA Inspection
•Boston Scientific Neuromodulation Corporation•April 8, 2026

Boston Scientific Neuromodulation Corporation – FDA Inspection, Apr 8, 2026

Record Details

This FDA Inspection record concerns Boston Scientific Neuromodulation Corporation, with an inspection on April 8, 2026, issued by the Los Angeles District Office, covering medical devices & rad health.

Company
Boston Scientific Neuromodulation Corporation
Inspection Date
April 8, 2026
Product Type
Medical Devices & Rad Health
Office
Los Angeles District Office
People
  • Janet Pulver (FDA Associated Person)
  • Jordan I. Abel (Investigator)
  • Linda Galindo
View Company Profile

ID · b9815226-8abe-4bb0-8e8f-e01b0a4c7696

Inspection Facts

Inspection number
1276849
FDA center
Medical Devices & Rad Health
Project area
Compliance: Devices
Outcome
Form 483 issued, view the record

FDA Citations

11
  1. 21 CFR 803.17Lack of Written MDR Procedures
  2. 21 CFR 803.50(a)(2)Individual Report of Malfunction
  3. ISO 13485:2016 Clause 4.1.2Risk-based approach not applied to QMS processes
  4. ISO 13485:2016 Clause 4.1.5Inadequate monitoring and control over outsourced processes
  5. ISO 13485:2016 Clause 7.1Records of risk management activities in product realization not maintained
  6. ISO 13485:2016 Clause 7.3.1Design and development procedures not documented
  7. ISO 13485:2016 Clause 7.4.3Impact of changes to purchased product not determined
  8. ISO 13485:2016 Clause 8.2.1Information gathered in feedback process not used as input into risk management
  9. ISO 13485:2016 Clause 8.2.2Complaint handling procedures not documented
  10. ISO 13485:2016 Clause 8.3.3Appropriate action not taken for nonconforming product after delivery or use

Showing 10 of 11 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Boston Scientific Neuromodulation Corporation

9
DateClassificationOfficeProject area
July 20, 2017Not classifiedLos Angeles District Office
November 17, 2016VAICenter for Devices and Radiological HealthCompliance: Devices
January 22, 2016VAICenter for Devices and Radiological HealthPostmarket Assurance: Devices
July 29, 2015NAICenter for Devices and Radiological HealthCompliance: Devices
April 25, 2013NAICenter for Devices and Radiological HealthCompliance: Devices
View all 9 other inspections on the company page
Other documents for Boston Scientific Neuromodulation Corporation
  • FDA Inspection 1034596 - 2017-07-20
  • FDA Inspection 994022 - 2016-11-17
  • FDA Inspection 955462 - 2016-01-22
  • FDA Inspection 936228 - 2015-07-29
  • FDA Inspection 828898 - 2013-04-25

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Boston Scientific Neuromodulation Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.